“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

Two technology leaders, Dario Amodei, CEO of Anthropic, and Nandan Nilekani, co-founder and chairman of Infosys, on how AI’s promise will ultimately hinge on diffusion, not just innovation.

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

Pilot runs of AI tools that assist farmers work out well but often run into patchy networks while scaling up. Thankfully, at ...

Alger Small Cap Focus Fund reviews Q4 2025 performance and the impact of the artificial intelligence capital cycle. Read the ...

As artificial intelligence reshapes geopolitics, economies and democratic processes, one reality is becoming impossible to ignore: AI is no longer just a technology conversation. It is a power ...

UN chief Antonio Guterres warned technology leaders Thursday of the risks of artificial intelligence, saying its future ...

Allies say McConnell has secured more than $60 billion in direct funding for Kentucky in his 40-plus years in the U.S. Senate ...

University of Surrey researchers discovered a compound known as nanostructured sodium vanadate hydrate (NVOH) – a layered sodium-based material that naturally contains water within its crystalline ...

The implementation of the agreement will thus become a test of whether “green trade” can advance climate goals through ...